MarketPulse
V

$VIR

2 articles found
2 positive
0 negative
0 neutral
The Motley FoolThe Motley Fool··Cory Renauer

Vir Biotech CEO Offloads $664K in Shares Amid Positive Clinical Pipeline

Vir Biotechnology CEO Marianne De Backer sold 72,559 shares worth $664,350, representing 6.76% of holdings. Sale aligns with historical patterns amid company's positive momentum.
VIRALPMYbiotechclinical trial results
BenzingaBenzinga··Rishabh Mishra

Mixed Signals in U.S. Equity Futures as Tariff Concerns Offset Corporate Earnings Gains

U.S. stock futures mixed Tuesday as tariff concerns offset strong corporate earnings. S&P 500 retreated while Dow and Nasdaq advanced amid investor uncertainty.
SPYQQQUBERWHRHPQ+2earningsstock market